News Release

CME Group Statement on Lehman Brothers Inc.

Mon Sep 15 2008

CHICAGO, Sept. 15 /PRNewswire-FirstCall/ -- In response to media inquiries CME Group (NASDAQ: CME), the world's largest and most diverse derivatives exchange, has issued the following statement:

Lehman Brothers Inc., the CME Group clearing member, continues to meet all of its obligations to CME Clearing and continues to operate as normal. 

CME Group's clearing member, Lehman Brothers Inc., is a subsidiary of  Lehman Brothers Holdings Inc., but is a separate company with its own accounts, assets and customers. These accounts, assets and customers are protected through a comprehensive federal statutory and regulatory regime and other financial safeguards and risk management protections provided by CME Clearing. All customer funds are required to be segregated from firm assets, held in specially identified accounts and are not subject to any creditors' claims against the firm.

CME Clearing provides a marketplace where futures and options on futures contracts are traded. CME Clearing clears, settles and guarantees all matched transactions in CME Group companies including CME, CBOT and NYMEX.  The financial integrity of CME Clearing is the foremost consideration of CME Group Management, its Board of Directors and its Clearing House Risk Committee. CME Group is vitally aware of its essential role in international financial markets and believes that its financial safeguard system, designed for the benefit and protection of CME Group markets, clearing members and their customers, is second to none. CME Clearing's financial safeguard systems and auditing systems have proved absolutely effective for over a century to protect customers and other members of its clearing house against any loss.

CME Group ( is the world's largest and most diverse derivatives exchange. Building on the heritage of CME, CBOT and NYMEX, CME Group serves the risk management needs of customers around the globe. As an international marketplace, CME Group brings buyers and sellers together on the CME Globex electronic trading platform and on trading floors in Chicago and New York. CME Group offers the widest range of benchmark products available across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and alternative investment products such as weather and real estate. CME Group is listed on NASDAQ under the symbol "CME".

The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex and E-mini, are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago. NYMEX, New York Mercantile Exchange, and ClearPort are trademarks of New York Mercantile Exchange. Inc. COMEX is a trademark of Commodity Exchange, Inc. Standard & Poor's, S&P 500 and S&P, S&P MidCap 400, Standard & Poor's Depositary Receipts and SPDR are trademarks of The McGraw-Hill Companies, Inc. NASDAQ, NASDAQ-100 and the NASDAQ-100 Index are trademarks of The Nasdaq Stock Market, Inc. Nikkei and Nikkei 225 are trademarks of Nihon Keizai Shimbun Inc. The Russell 2000 Index and Russell 1000 Index are registered trademarks of Frank Russell Co. TRAKRS and Total Return Asset Contracts are trademarks of Merrill Lynch & Co., Inc. GSCI is a trademark of Goldman Sachs & Co. Morgan Stanley Capital International, MSCI, and EAFE are trademarks of MSCI. FTSE/Xinhua China 25 is a trademark of FTSE Xinhua Index Limited. Dow Jones and Dow Jones Industrial Average are trademarks of Dow Jones & Company, Inc. CDR Liquid 50 NAIG is a trademark of Credit Derivatives Research LLC. These trademarks are used herein under license. All other trademarks are the property of their respective owners. Further information about CME Group and its products can be found at



CONTACT: Media, Allan Schoenberg, +1-312-930-8189, or Mary Haffenberg,
+1-312-930-3435,, or Investors, John Peschier,
+1-312-930-8491, all of CME Group

Web site:

Corporate Communications

+1 312 930 3434